Trial intelligence / Profile preview

SLN-containing finasteride for androgenetic alopecia

IRCT20181128041780N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of finasteride in androgenetic alopecia (AGA), sponsored by Mashhad University of Medical Sciences. Started Nov 2018; status: completed.

02

Drugs

finasteride
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20181128041780N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181128041780N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call